leerink guidance--fresh in from my broker, page-4

The generics are moving in on Lovenox so whatever claims about number of syringes SNY used in 2012 is baseless for future years imo.


Enoxaparin is not protected by US patent due to inequitable conduct on the filing of Patent No. 5,389,618

http://en.wikipedia.org/wiki/Enoxaparin_sodium

http://www.fiercepharma.com/special-reports/enoxaparin-top-us-generic-blockbusters